No Data
Xianle Health: Report for the third quarter of 2024
Sirio Pharma (300791.SZ): Net income in the third quarter was 85.3283 million yuan, a year-on-year increase of 1.63%.
Galaxy News October 23rd | Sirio Pharma (300791.SZ) released its third quarter report for 2024, with quarterly revenue of 1.058 billion yuan, a year-on-year increase of 10.43%; net income attributable to the shareholders of the listed company was 85.3283 million yuan, a year-on-year increase of 1.63%; net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 81.8877 million yuan, a year-on-year decrease of 4.62%; basic earnings per share of 0.47 yuan.
Sirio Pharma (300791.SZ) released its performance for the first three quarters, with a net income of 0.24 billion yuan, a year-on-year increase of 29.52%.
Sirio Pharma (300791.SZ) released the third quarter report for 2024, with revenue for the first three quarters reaching 30...
Sirio Pharma (SZSE:300791) Seems To Use Debt Quite Sensibly
Private Companies Invested in Sirio Pharma Co., Ltd. (SZSE:300791) up 13% Last Week, Insiders Too Were Rewarded
Sirio Pharma Co., Ltd.'s (SZSE:300791) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Take Care Before Diving Into The Deep End On Sirio Pharma Co., Ltd. (SZSE:300791)No Data
No Data
